AstraZeneca Pharma India Ltd

NSE: ASTRAZEN · BSE: 506820 · Pharmaceuticals & Biotechnology · 42 announcements

Share price: ₹5,918.00
Market cap: ₹14,795 Cr
Revenue (annual): ₹2,276 Cr
Net profit (annual): ₹187.5 Cr
P/E (TTM): 87.2×Sector 47.3×
Promoter holding: 75.00%+0.00% QoQ
FII holding: 2.68%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Legal & Regulatory 3 Other Announcement 2 Management Change 2 Results Update 1 Regulatory Approval 1 Financial Results 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

8 Aug 2026 11:34 IST BSE

Regulatory Approval

AstraZeneca Pharma India Regulatory Approval

AstraZeneca Pharma received CDSCO permission to market 'Enhertu' for an additional breast cancer indication in India. This expands the drug's therapeutic usage under regulatory approval.

Read the filing ↗